You Position: Home > Paper

Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis

( views:580, downloads:328 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF NEUROSURGERY
Issue:
2
DOI:
10.3760/cma.j.issn.1001-2346.2010.02.003
Key Word:
椎动脉狭窄;椎底动脉供血不足;后循环缺血;血管成形术;支架;Vertebral artery stenosis;Vertebrobasilar insufficiency;Posterior circulation ischemia;Angioplasty;Stents

Abstract: Objective To evaluate mid - long outcomes of drug - eluting stent (DES) for vertebral artery origin stenosis. Methods The demographics, indications for treatment, procedural technique, and clinical and radiographic follow - up were analyzed retrospectively in 47 consecutive patients treated with drug -eluting stents. Results 47 patients with 49 lesions were successfully treated with stent. No peri -procedural complications occurred. The mean degree of stenosis reduced from 72% to 9%. Symptoms were resolved in 11 cases, improved in 30 cases, unchanged in 6 cases. During follow - up for 2 - 48 months (mean 28. 3 months), tow cases had posterior circulation transient ischemic attack (TIA). Angiographic fowllow -up of 3 -34 months was obtained in 28 patients (59%) with a mean of 12. 2 months. Restenosis inside the stent (IRS) was observed in 2 patients and one present with drop attack. Stent fracture occurred in 4 patients, in which 2 cases with IRS. Conclusions VA origin stenosis can be treated safely and effectively with DES. Compared with the bare stent, DES can significantly reduces the rates of restenosis.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn